These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21779300)
1. Thinning of the corpus callosum and cerebellar atrophy is correlated with phenotypic severity in a family with spastic paraplegia type 11. Rajakulendran S; Paisán-Ruiz C; Houlden H J Clin Neurol; 2011 Jun; 7(2):102-4. PubMed ID: 21779300 [TBL] [Abstract][Full Text] [Related]
2. Clinical heterogeneity and genotype-phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations (SPG11). Paisan-Ruiz C; Nath P; Wood NW; Singleton A; Houlden H Eur J Neurol; 2008 Oct; 15(10):1065-70. PubMed ID: 18717728 [TBL] [Abstract][Full Text] [Related]
3. Pattern reversal visual evoked potentials (prVEPs) in autosomal recessive hereditary spastic paraplegia with thin corpus callosum (ARHSPTCC) patients with SPG 11 mutations in Saudi Arabia, cross section hospital base study. Alfaidi N; Sobahy T; Ali Q; Al Said Y; Karim G; Khan H; Kurdi K; Cupler E J Neurol Sci; 2022 Mar; 434():120144. PubMed ID: 35074613 [TBL] [Abstract][Full Text] [Related]
4. Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. Schüle R; Schlipf N; Synofzik M; Klebe S; Klimpe S; Hehr U; Winner B; Lindig T; Dotzer A; Riess O; Winkler J; Schöls L; Bauer P J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1402-4. PubMed ID: 19917823 [TBL] [Abstract][Full Text] [Related]
5. A case report of SPG11 mutations in a Chinese ARHSP-TCC family. Zhang L; McFarland KN; Jiao J; Jiao Y BMC Neurol; 2016 Jun; 16():87. PubMed ID: 27256065 [TBL] [Abstract][Full Text] [Related]
7. Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa-responsive Parkinsonism. Guidubaldi A; Piano C; Santorelli FM; Silvestri G; Petracca M; Tessa A; Bentivoglio AR Mov Disord; 2011 Feb; 26(3):553-6. PubMed ID: 21381113 [TBL] [Abstract][Full Text] [Related]
8. Expanding the clinical spectrum of SPG11 gene mutations in recessive hereditary spastic paraplegia with thin corpus callosum. Abdel Aleem A; Abu-Shahba N; Swistun D; Silhavy J; Bielas SL; Sattar S; Gleeson JG; Zaki MS Eur J Med Genet; 2011; 54(1):82-5. PubMed ID: 20971220 [TBL] [Abstract][Full Text] [Related]
9. Research on clinical and molecular genetics of hereditary spastic paraplegia 11 patients in China. DU J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1729-1732. PubMed ID: 36748384 [TBL] [Abstract][Full Text] [Related]
10. Novel mutations c.[5121_5122insAG]+[6859C>T] of the SPG11 gene associated with cerebellum hypometabolism in a Chinese case of hereditary spastic paraplegia with thin corpus callosum. Ma J; Xiong L; Chang Y; Jing X; Huang W; Hu B; Shi X; Xu W; Wang Y; Li X Parkinsonism Relat Disord; 2014 Feb; 20(2):256-9. PubMed ID: 24315199 [TBL] [Abstract][Full Text] [Related]
12. Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity. Pippucci T; Panza E; Pompilii E; Donadio V; Borreca A; Babalini C; Patrono C; Zuntini R; Kawarai T; Bernardi G; Liguori R; Romeo G; Montagna P; Orlacchio A; Seri M Eur J Neurol; 2009 Jan; 16(1):121-6. PubMed ID: 19087158 [TBL] [Abstract][Full Text] [Related]
13. SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. Paisan-Ruiz C; Dogu O; Yilmaz A; Houlden H; Singleton A Neurology; 2008 Apr; 70(16 Pt 2):1384-9. PubMed ID: 18337587 [TBL] [Abstract][Full Text] [Related]
14. An autopsied case report of spastic paraplegia with thin corpus callosum carrying a novel mutation in the SPG11 gene: widespread degeneration with eosinophilic inclusions. Hayakawa M; Matsubara T; Mochizuki Y; Takeuchi C; Minamitani M; Imai M; Kosaki K; Arai T; Murayama S BMC Neurol; 2022 Jan; 22(1):2. PubMed ID: 34979968 [TBL] [Abstract][Full Text] [Related]
15. Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients. Du J J Clin Neurosci; 2021 Mar; 85():67-71. PubMed ID: 33581793 [TBL] [Abstract][Full Text] [Related]
16. Transactivation response DNA-binding protein of 43 kDa proteinopathy and lysosomal abnormalities in spastic paraplegia type 11. Mori S; Honda H; Hamasaki H; Sasagasako N; Suzuki SO; Furuya H; Taniwaki T; Iwaki T Neuropathology; 2021 Aug; 41(4):253-265. PubMed ID: 34031922 [TBL] [Abstract][Full Text] [Related]
17. SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration. Orlén H; Melberg A; Raininko R; Kumlien E; Entesarian M; Söderberg P; Påhlman M; Darin N; Kyllerman M; Holmberg E; Engler H; Eriksson U; Dahl N Am J Med Genet B Neuropsychiatr Genet; 2009 Oct; 150B(7):984-92. PubMed ID: 19194956 [TBL] [Abstract][Full Text] [Related]
18. Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations. Chen J; Zhao Z; Shen H; Bing Q; Li N; Guo X; Hu J BMC Neurol; 2022 May; 22(1):180. PubMed ID: 35578252 [TBL] [Abstract][Full Text] [Related]
19. ZFYVE26/SPASTIZIN and SPG11/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis. Vantaggiato C; Panzeri E; Castelli M; Citterio A; Arnoldi A; Santorelli FM; Liguori R; Scarlato M; Musumeci O; Toscano A; Clementi E; Bassi MT Autophagy; 2019 Jan; 15(1):34-57. PubMed ID: 30081747 [TBL] [Abstract][Full Text] [Related]